Reproductive and developmental safety evaluation of new pharmaceutical compounds

Reproductive and Developmental Toxicology

Volumn , Issue , 2011, Pages 89-109

  Garg, Ramesh C ^a   Bracken, William M ^a   M Hoberman, Alan ^b  

^a ABBOTT LABORATORIES   (United States)

^b CHARLES RIVER LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884420292     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382032-7.10008-6     Document Type: Chapter

References (143)

1. A.N. Antonov (1947) Children born during the siege of Leningrad in 1942. J Pediatr 30 250-259
2. M. Balls and E. Hellsten (2002) The use of scientifically validated in vitro tests for embryotoxicity. ATLA 30 265-273
3. P.C. Barrow (2003) Reproductive toxicology studies and immunotherapeutics. Toxicology 185 205-212
4. P.C. Barrow (2009) Reproductive toxicity testing for pharmaceuticals under ICH. Reprod Toxicol 28 172-179
5. P.C. Barrow and G. Ravel (2005) Immune assessment in developmental and juvenile toxicology: practical considerations for the regulatory safety testing of pharmaceuticals. Reg Toxicol Pharmacol 43 35-44
6. Bass R (1993) Report on Progress Since ICH-1, The Second International Conference on
7. B. Bolon, T.J. Bucci, A.R. Warbritton, J.J. Chen, D.R. Mattison and J.J. Heindel (1997) Differential follicle counts as a screen chemically-induced ovarian toxicity in mice: results from continuous breeding bioassays. Fund Appl Toxicol 39 1-10
8. M.B. Bracken (1990) Oral contraceptives and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol 76 552-557
9. A. Brinker, C. Kornegay and P. Nourjah (2005) Trends on adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies. Arch Dermatol 141 563-569
10. T. Brodniewicz-Proba (2008) The scope and requirements related to preclinical and clinical studies of a new medicinal product, including biotechnological and biosimilar products. Acta Polaniae Pharmaceutica –. Drug Research 65 641-645
11. L.A. Buckley, K. Benson, K. Davis-Bruno, M. Dempster, G.L. Finch, P. Harlow, H.G. Haggerty, T. Hart, L. Kinter, J.K. Leighton, J. McNulty, L. Roskos, H. Saber, A. Stauber and M. Tabrizi (2008) Nonclinical aspects of biopharmaceutical development: discussion of case studies at a PhRMA-FDA workshop. Int J Toxicol 27 303-312
12. Canada (1977) Health Protection Branch, The Testing of Chemicals for Carcinogenicity, Mutagenicity and Teratogenicity. Canada: Ministry of Health and Welfare
13. Centers for Disease Control and Prevention (CDC) (2009) Birth Defects, March 11, 2009, cited in March of Dimes: Pregnancy & Newborn Health Education Center, Quick Reference: Fact Sheet, June 2009
14. R. Chapin, K. Augustine-Rauch, B. Beyer, G. Daston, R. Finnell, T. Flynn, S. Hunter, P. Mirkes, K.S. O'Shea, A. Piersma, D. Sandler, P. Vanparys and G.V. Maele-Fabrey (2008) State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture and zebrafish. Birth Defect Res (Part B) 83 446-456
15. I.J. Chasnoff (1992) Cocaine, pregnancy and the growing child. Curr Probl Pediatr 22 302-321
16. G.J. Chellman, J.L. Bussiere, N. Makori, P.L. Martin, Y. Ooshima and G.F. Weinbauer (2009) Developmental and reproductive toxicology studies in nonhuman primates. Birth Defect Res (Part B) 86 446-462
17. M.S. Christian (1993) Harmonization of reproductive guidelines: a perspective from the International Federation of Teratology Societies. J Am Coll Toxicol 11(3), 299-302
18. S.K. Clarren (1981) Recognition of fetal alcohol syndrome. JAMA 245 2436-2439
19. D.J. Clegg (1979) Animal reproduction and carcinogenicity studies in relation to human safety evaluations. Devel Toxicol Environ Sci 4 45-59
20. T.F.X. Collins (2006) History and evolution of reproductive and developmental toxicology guidelines. Current Pharma Design 12 1449-1465
21. Committee on the Safety of Medicines (CSM) (1974) Notes for Guidance on Reproduction Studies. Department of Health and Social Security, Great Britain
22. A. Czeizel (1987) Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reprod Toxicol 1 183-188
23. P.F. D'Arcy and D.W.G. Harron (Eds) (1992) Topic 2: Reproductive toxicology. Proceedings of the First International Conference on Harmonisation The Queen's University of Belfast 255
24. G.P. Daston (1996) The theoretical and empirical case for in vitro developmental toxicity screens, and potential applications. Teratology 53 339-344
25. J.M. DeSesso (1996) Comparative embryology. R.D. Hood (Eds) Handbook of Developmental Toxicology New York: CRC Press 111-174
26. J.H. Dickson (1977) Congenital deformities associated with Bendectin. Can Med Assoc J 117 691-692
27. D. Donnai and R. Harris (1978) Unusual fetal malformations after antiemetics in pregnancy. BMJ 1 691-692
28. W.J. Dougherty, F. Coulston and L. Golberg (1974) Toxicity of methylmercury in pregnant rhesus monkeys. Toxicol Appl Pharmacol 29 138 abstract
29. T.R. Einarson, G. Koren, D. Mattice and O. Schechter-Tsafriri (1990) Maternal spermicide use and adverse reproductive outcome: a meta analysis. Am J Obstet Gynecol 162 655-660
30. T.R. Einarson, J.S. Leeder and G. Koren (1988) A method for meta-analysis of epidemiological studies. Drug Intell Clin Pharm 22 813-824
31. F.W. Ellis and J.R. Pick (1980) An animal model of the fetal alcohol syndrome in beagles. Alcohol Clin Exp Res 4 123-134
32. European Economic Community (1988) The Rules Governing Medicinal Products in the European Community, Vol. III, Guidelines on the Quality, Safety and Efficacy of Medicinal Products for Human Use. Office of Official Publications of the European Communities, Brussels
33. A.G. Fantel and B.J. Macphail (1982) The teratogenicity of cocaine. Teratology 26 17-19
34. A.G. Fantel, T.H. Shepard, L.L. Newell-Morris and B.C. Moffett (1977) Teratogenic effects of retinoic acid in pigtail monkeys (Macaca nemestrina). I. General Features. Teratology 15 65-71
35. R.H. Finnell (1981) Phenytoin-induced teratogenesis: a mouse model. Science 211 483-484
36. R.H. Finnell, G.D. Bennett, S.B. Karras and V.K. Mohl (1988) Common hierarchies of susceptibilities to the induction of neural tube defect in mouse embryo by valproic acid and its 4-propyl-4- pentenoic acid metabolite. Teratology 38 313-320
37. O.G. Fitzhugh (1959) Chronic oral toxicity. Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics Austin, Texas: Association of Food and Drug Officials of the United States 36
38. V.H. Frankos (1985) FDA perspectives on the use of teratology data for human risk assessment. Fund Appl Toxicol 5 615-625
39. F.C. Fraser, W. Lenz, J. Warkany, F.O. Kelsey, T. Heshka, T.D. Stevens, R.L. Brent and L.B. Holmes (1988) Thalidomide symposium; thalidomide retrospective: what did we learn? Paper presented at the 26th Annual Meeting of the Teratology Society, July 6–10, 1986, Boston, MA. Teratology 38 201-202
40. I.D. Fratta, E.B. Sigg and K. Maiorana (1965) Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice. Toxicol Appl Pharmacol 7 268-286
41. L. Goldberg (Eds) (1974) Recommendations of a conference as stated by the conference chairman. In Carcinogenesis Testing of Chemicals Cleveland: CRC Press 123
42. S. Gottlieb (2008) Biosimilars: policy, clinical and regulatory considerations. Am J Health Syst Pharm 65 S2-S8
43. N.M. Gregg (1941) Congenital cataract following German measles in mothers. Trans Ophthalmol Soc Austral 3 35-46
44. F. Hale (1933) Pigs born without eyeballs. J Heredity 24 105-106
45. F. Hale (1935) The relation of vitamin A to anophthalmos in pigs. Am J Ophthamol 18 1087-1093
46. J.G. Hall, R.M. Pauli and K.M. Wilson (1980) Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68 122-140
47. J.W. Hanson and D.W. Smith (1975) The fetal hydantoin syndrome. J Pediatr 87 285-290
48. Harbison RD (1969) Studies on the mechanism of teratogenic action and neonatal pharmacology of diphenylhydantoin (PhD thesis. Iowa State University, Iowa, USA)
49. Harmonisation, Orlando, Florida, October 27–9, 1993
50. J.J. Heindel (1999) VII Oocyst quantitation and ovarian histology. An Evaluation and Interpretation of Reproductive Endpoints for Human Health Risk Assessment Washington DC: Int Life Sci Institute 57-74
51. J.D. Henderson (1992) Current issues in bioequivalence determination. Appl Clin Trials 1 44-49
52. A.L. Herbst, H. Ulfelder and D.C. Poskanzer (1971) Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. New Eng J Med 284 878-881
53. M.P. Holsapple (2003) Developmental immunotoxicity testing: a review. Toxicology 185 193-203
54. N. Horie, H. Higuchi, S. Kawamura, K. Saito and N. Suzuki (2007) Safety evaluation study using embryonic stem (ES) cells. Sumitomo Kagaku 2007-I 1-7. (abstract)
55. A.M. Howe and W.S. Webster (1992) The warfarin embryopathy: a rat model showing maxillonasal hypoplasia and other skeletal disturbances. Teratology 46 379-390
56. Interagency Regulatory Liaison Group (1986) Interagency regulatory liaison group workshop on reproductive toxicity risk assessment. Environ Hlth Pers 66 193-221
57. Interagency Regulatory Liaison Group (IRLG) (1980) Recommended guideline for teratogenicity studies in the rat, mouse, hamster or rabbit, April
58. International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline; Detection of Toxicity to Reproduction for Medicinal Products, June 24, 1993. Presented at The Second International Conference on Harmonisation, Orlando, Florida, October 27–9, 1993
59. C.M. Jackson (1925) Effects of Inanition and Malnutrition upon Growth and Structure. Philadelphia: P. Blakiston's Son & Co
60. S.J. Jacobson, K. Jones, K. Johnson, L. Ceolin, P. Kaur, D. Sahn, A.E. Donnenfeld, M. Rieder, R. Santelli, J. Smythe, E.T. Pastuszak Einarson T and G. Koren (1992) Prospective multicenter study of pregnancy outcome after lithium exposure during first trimester. Lancet 339 530-533
61. E. Jager-Roman, A. Deichi, S. Jakob, A. Hartmann, S. Koch, D. Rating, R. Steldinger, H. Nau and H. Helge (1986) Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 108 997-1004
62. J. Jarrell, E.V. Young Lai, R. Barr, A. McMahon, L. Belbeck and G. O'Connell (1987) Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rats. Cancer Res 47 2340-2343
63. H. Jick, A.M. Walker, K.L. Rothman, J.R. Hunter, L.B. Holmes, R.N. Watkins, D.C. D'Ewart, A. Danford and S. Madsen (1981) Vaginal spermicides and congenital disorders. JAMA 245 1329-1332
64. E.M. Johnson and M.S. Christian (1983) When is a teratology study not an evaluation of teratogenicity? J Am Coll Toxicol 3 431-434
65. S.V. Kane and L.A. Acquah (2009) Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. The Am J Gastroenterol 104 228-233
66. F.O. Kelsey (1988) Thalidomide update: regulatory aspects. Teratology 38 221-226
67. B.J. Koos and L. Longo (1976) Mercury toxicity in pregnant women, fetus and newborn infant. Am J Obstet Gynecol 126 390-409
68. G. Koren, A. Pastuszak and S. Ito (1998) Drugs in pregnancy. N Eng J Med 338 1128-1137
69. E.J. Lammer, D.J. Chen, R.M. Hoar, N.D. Agnish, P.J. Benke, J.T. Braun, C.J. Curry, P.M. Fernhoff, A.W. Grix, I.T. Lott, J.M. Richard and S.C. Sun (1985) Retinoic acid embryopathy. N Eng J Med 313 837-841
70. E.J. Lammer, L.E. Sever and G.P. Oakley Jr. (1987) Teratogen update: valproic acid. Teratology 35 465-473
71. A.J. Lehman, E.P. Laug, G. Woodard, J.H. Draize, O.G. Fitzhugh and A.A. Nelson (1949) Procedures for the appraisal of the toxicity of chemicals in foods. Food Drug Cosmet Law J 4 412-434
72. W. Lenz (1961) Kindliche missbildungen nach medikament wahrend der draviditat? Deutsch Med Wochenschr 86 2555
73. B. Lutiger, K. Graham, T.R. Einarson and G. Koren (1991) Relationship between gestational cocaine use and pregnancy outcome: meta-analysis. Teratology 44 405-414
74. P.L. Martin, W. Breslin, M. Rocca, D. Wright and J. Cavagnaro (2009) Considerations in assessing the developmental and reproductive toxicity potential of biopharmaceuticals. Birth Defect Res (Part B) 86 176-203
75. Mathews TJ, MacDorman MF (2008) Infant mortality statistics from the 2005 period linked birth/infant death data set. National Vital Statistics Reports, volume 57: July 30, 2008. Cited in March of Dimes: Pregnancy & Newborn Health Education Center, Quick Reference: Fact Sheet, June 2009
76. H. Matsumoto, G. Koya and T. Takeuchi (1965) Fetal Minamata disease: a neuropathological study of two cases of intrauterine intoxication by a methylmercury compound. J Neuropathol Exp Neurol 24 563-574
77. W.G. McBride (1961) Thalidomide and congenital abnormalities. Lancet 278 1358
78. P.M. McKeigue, S.H. Lamm, S. Linn and J.S. Kutcher (1994) Bendectin and birth defects. I. A meta-analysis of the epidemiological studies. Teratology 50 27-37
79. R.M. McLain and L. Langhoff (1979) Teratogenicity of diphenylhydantoin in New Zealand white rabbits. Toxicol Appl Pharmacol 48 A32. (abstract)
80. Ministry of Health and Welfare, Japan (MHW), On Animal Experimental Methods for Testing the Effects of Drugs on Reproduction, Notification No. 529 of the Pharmaceutical Affairs Bureau, Ministry of Health and Welfare, March 31, 1975
81. F.S. Muhammad, A.K. Goode, N.D. Kock, E.A. Arifin, J.M. Cline, M.R. Adams, P.B. Hoyer, P.J. Christian, S. Isom, J.R. Japlan and S.E. Appt (2009) Effect of 4-vinylcyclohexene diepoxide on peripubertal and adult Sprague-Dawley rats: ovarian, clinical, and pathologic outcomes. Comp Med 59 46-59
82. H. Nau (1986) Species differences in pharmacokinetics and drug teratogenesis. Environ Health Perspect 70 113-129
83. D.A. New (1978) Whole-embryo culture and the study of mammalian embryo during organogenesis. Biol Rev Camb Philos Soc 53 81-122
84. J.J. Nora, A.H. Nora, J. Blu, J. Ingram, A. Fountain, M. Peterson, R.H. Lortscher and W.J. Kimberling (1978) Exogenous progestogen and estrogen implicated in birth defects. JAMA 240 837-843
85. J.J. Nora, A.H. Nora and J.M. Toews (1974) Lithium Ebstein's anomaly, and other congenital heart defects. Lancet 304 594-595
86. Organization for Economic Cooperation and Development (OECD): Final Report-OECD short-term and long-term toxicology groups. Teratogenicity December 31, 1979, 110
87. A.K. Palmer (1973) Some thoughts on reproductive studies for safety evaluations. Proc Euro Soc Study Drug Tox 14 79-90
88. A.K. Palmer (1981) Regulatory requirements for reproductive toxicology: theory and practice. C.A. Kimmel, J. Buelke-Sam (Eds) Developmental Toxicology New York: Raven Press 259
89. J.A. Paquette, S.W. Kumpf, R.D. Streck, J.J. Thompson, R.E. Chapin and D.B. Stedman (2008) Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry. Birth Defect Res (Part B) 83 104-111
90. Pharmaceutical Manufacturers Association (PMA) (1965) Second Workshop in Teratology. Supplement to the Teratology Workshop Manual (A collection of lectures and demonstrations from the Second Workshop in Teratology held January 25–30, 1965, Berkeley, California), Pharmaceutical Manufacturers Association, Washington DC
91. Pharmaceutical Research and Manufacturers of America (2008) Pharmaceutical Industry Profile 2008. Washington, DC: PhRMA, March 2008
92. C.A. Picut, C.L. Swanson, K.L. Scully, V.C. Roseman, R.F. Parker and A.K. Remick (2008) Ovarian follicle count using proliferating cell nuclear antigen (PCNA) and semi-automated image analysis in rats. Toxicol Pathol 36 674-679
93. F.B. Pipkin, S.R. Turner and E.M. Symonds (1980) Possible risk with captopril in pregnancy: some animal data. Lancet 1 1256
94. L. Ramen-Wilms, A.L. Tseng, S. Wighardt, T.R. Einarson and G. Koren (1995) Fetal genital effects of first trimester sex hormones exposure: a meta analysis. Obstet Gynec 85 141-149
95. F.W. Rosa (1991) Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 324 674-677
96. F.W. Rosa, L.A. Bosco, C.F. Graham, J.B. Milstien, D. Michael and J. Creamer (1989) Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet Gynecol 74 371-374
97. L. Rosenberg, A.A. Mitchell, J.L. Parsells, H. Pashayan, C. Luvik and S. Shapiro (1983) Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 309 1282-1285
98. I. Saxen (1975) Association between oral cleft and drugs taken during pregnancy. Int J Epidemiol 4 37-44
99. J.L. Schardein (1980) Congenital abnormalities and hormones during pregnancy: a clinical review. Teratology 22 251-270
100. J.L. Schardein (1993) Chemically Induced Birth Defects. 2nd ed. rev New York: Marcel Dekker
101. B.A. Schwetz, K.S. Rao and C.N. Park (1980) Insensitivity of test for reproductive problems. J Environ Pathol Toxicol 3 81-98
102. D. Scolnik, I. Nulman, J. Rovet, D. Gladstone, D. Czuchta, H.A. Gardner, R. Gladstone, P. Ashby, R. Weksberg, T. Einarson and G. Koren (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271 767-770
103. P.H. Shiono and J.L. Mills (1984) Oral clefts and diazepam use during pregnancy. N Engl J Med 311 919-920
104. K. Shiromizu, S. Thorgeirsson and D. Mattison (1984) Effect of cyclophosphamide on oocyte and follicle number in Sprague-Dawley rats, C57BL/6N and DBA/2N mice. Pediatr Pharmacol 4 213-321
105. W.J. Shoemaker, L.Y. Koda, C.A. Shoemaker and F.E. Bloom (1980) Ethanol effects in chick embryo: cerebellar Purkinje neurons. Neurobehav Toxicol 2 239-242
106. D. Slone, V. Siskind, O.P. Heinonen, R.R. Monson, D.W. Kaufman and S. Shapiro (1976) Aspirin and congenital malformations. Lancet 307 1373-1375
107. C.A. Smith (1947) Effects of maternal undernutrition upon the newborn infant in Holland (1944–1945). J Pediatr 30 229-243
108. G.F. Somers (1962) Letter to the editor. Lancet 1 912
109. H. Spielmann (2009) The way forward in reproductive/developmental toxicity testing. ATLA 37 641-656
110. R.E. Staples (1974) Detection of visceral alterations in mammalian fetuses. Presented at the Teratology Soc 14th Annual Meeting, Vancouver, Canada. Teratology 9 A37-A38. (abstract)
111. R.E. Staples and J.L. Schnell (1964) Refinement in rapid clearing technique in the KOH-alizarin red S method for fetal bone. Stain Technol 39 61-63
112. J. Stewart (2009) Developmental toxicity testing of monoclonal antibodies: an enhanced pre- and postnatal study design option. Reprod Toxicol 28(2), 220-225
113. A.P. Streissguth, J.M. Aase, S.K. Clarren, S.P. Randels, R.A. LaDue and D.F. Smith (1991) Fetal alcohol syndrome in adolescents and adults. JAMA 265 1961-1967
114. J.L. Stuckhardt and P.M. Poppe (1984) Fresh visceral examination of rat and rabbit fetuses used in teratogenicity testing. Teratogenesis, Carcinogenesis and Mutagenesis 4 181-188
115. K.K. Sulik, M.C. Johnston and M.A. Webb (1981) Fetal alcohol syndrome: embryogenesis in a mouse model. Science 214 936-938
116. F.M. Sullivan and P.R. McElhatton (1977) A comparison of the teratogenic activity of the antiepileptic drugs carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin and pyrimidone in mice. Toxicol Appl Pharmacol 40 365-378
117. T. Tanimura (1990) Japanese perspectives on the reproductive and developmental toxicity evaluation of pharmaceuticals. J Amer Coll Toxicol 9 27-37
118. M. Tatetsu (1968) Experimental manifestation of "congenital minamata disease". Psychiatr Neurol Jpn 70 162
119. Teratology Society, Teratology Society position paper (1987) Recommendations for vitamin A use during pregnancy. Teratology 35 269-275
120. US Environmental Protection Agency (1998) Health effects test guidelines (OPPTS 870.3800). Reproductive infertility effects. Available at: http://www.epa.gov/docs/OPPTS_Harmonized/870_Health_Effects_Test_Guidelines/Drafts/870.3800.txt.html
121. US Environmental Protection Agency (EPA), Christian MS, Voytek PE (1982) In Vivo Reproductive and Mutagenicity Tests, US Environmental Protection Agency, Washington DC. National Technical Information Service, US Department of Commerce, Springfield, VA 22161
122. US Food and Drug Administration (1966) Guidelines for reproduction studies for safety evaluation of drugs for human use. Washington DC, FDA, 5 pp
123. US Food and Drug Administration (2001) Reviewer Guidance: integration of study results to assess concerns about human reproductive and developmental toxicities. Draft Guidance Rockville, MD, Center for Drug Evaluation and Research
124. US Food and Drug Administration (2008) Proposed Rule: contents and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Federal Register 73 Number 104, Thursday May 29, 2009
125. US Food and Drug Administration (FDA) (1982) Toxicological Principles and Procedures for Priority Based Assessment of Food Additives (Red Book). Guidelines for Reproduction Testing with a Teratology Phase, Bureau of Foods. Washington, DC: US Food and Drug Administration 80
126. US Food and Drug Administration (FDA) (1993) Draft – Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food (Red Book II). Guidelines for Reproduction and Developmental Toxicity Studies, Center for Food Safety and Applied Nutrition. Washington DC: US Food and Drug Administration 123
127. B.E. Walker (1971) Induction of cleft palate in rats with antiinflammatory drugs. Teratology 4 39-42
128. J. Warkany (1965) Development of experimental mammalian teratology. J.G. Wilson, J. Warkany (Eds) Teratology Principles and Techniques University of Chicago Press 1
129. J. Warkany and R.C. Nelson (1940) Appearance of skeletal abnormalities in the offspring of rats reared on a deficient diet. Science 92 383-384
130. J. Warkany and R.C. Nelson (1941) Skeletal abnormalities in offspring of rats reared on deficient diets. Anat Rec 79 83-100
131. W.T. Weathers, M.M. Crane, K.J. Sauvain and D.W. Blackhurst (1993) Cocaine use in women from defined population: prevalence at delivery and effect on growth in infants. Pediatrics 91 350-354
132. L.S. Welage, D.M. Kirking, F.J. Ascione and C.A. Gaither (2001) Understanding the scientific issues embedded in the generic drug approval process. J Am Pharm Assn 41 856-867
133. M.M. Werler, A.A. Mitchell and S. Shapiro (1989) The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med 321 1639-1642
134. S. Whitlow, H. Burgin and N. Clemann (2007) The embryonic stem cell test for the early selection of pharmaceutical compounds. ALTEX 24 3-6
135. P. Wier (2006) Use of toxicokinetics in developmental and reproductive toxicology. R.D. Hood (Eds) Developmental and Reproductive Toxicology 2nd edition Boca Raton, London, New York: CRC, Taylor & Francis Group 571-597
136. O.K. Wilby, S.A. Tesh, F.W. Ross and J.M. Tesh (1987) Effects of lithium on development in vitro and in vivo in the rat. Teratology 35 69. (abstract)
137. J.G. Wilson (1965) Methods for administering agents and detecting malformations in experimental animals. Teratology, Principles and Techniques Chicago: University of Chicago Press 262
138. J.G. Wilson (1973) Principles of teratology. Environment and Birth Defects New York: Academic Press 11
139. J.G. Wilson and J. Warkany (1965) Teratology: Principles and Techniques (Lectures and demonstrations given at the First Workshop in Teratology, University of Florida, February 2–8, 1964). Chicago: University of Chicago Press
140. D.L. Wise, J. Buschmann, M.H. Feuston, J.E. Fisher, K.W. Hew, A.M. Hoberman, S.A. Lerman, Y. Ooshima and D.G. Stump (2009) Embryo–fetal developmental toxicity study design for pharmaceuticals. Birth Defect Res (Part B) 86 418-428
141. J.R. Wood Jr., M.A. Plessinger and K.E. Clark (1987) Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 257 957-961
142. World Health Organization (WHO) (1967) Principles for the testing of drugs for teratogenicity. WHO Tech. Rept. Series No. 364, Geneva
143. S.S. Zilva, J. Goulding, J.C. Brummond and K.H. Coward (1921) The relation of the fat-soluble factor to rickets and growth in pigs. Biochem J 15 427-437